News
10-31-2011, 10:00 PM
Whitehead Institute scientists report that patients whose estrogen receptor (ER)-positive breast cancers have high levels of the ancient cellular survival factor heat shock factor 1 (HSF1) experience poor outcomes—including increased mortality.
More... (http://www.news-medical.net/news/20111101/ER-positive-breast-cancer-patients-with-high-levels-of-heat-shock-factor-1-experience-poor-outcomes.aspx)
More... (http://www.news-medical.net/news/20111101/ER-positive-breast-cancer-patients-with-high-levels-of-heat-shock-factor-1-experience-poor-outcomes.aspx)